This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Edgar D. Staren, MD, PhD; Christopher Salerno, MD; Anthony Rongione, MD; Thomas R. Witt, MD; L. Penfield Faber, MD

Arch Surg. 1992;127(11):1282-1284.

Abstract
• Thirty-three patients treated primarily with surgical excision of pulmonary metastases from breast cancer were compared with 30 patients treated primarily with systemic chemohormonal therapy. Treatment for patients in the surgical group included pulmonary resection alone in 20, resection plus adjuvant systemic therapy in nine, and resection plus adjuvant radiation therapy in four. Treatment for patients in the medical group included systemic therapy alone in 22 and systemic therapy plus local radiation therapy in eight. Mean survival in the surgical group was significantly longer than that in the medical group, even when only those patients who manifested single pulmonary nodules were compared (58 months vs 34 months). The overall 5-year survival rate after treatment of lung metastasis was significantly greater for the surgical group than for the medical group (36% vs 11 %). The results of this study indicate that surgical resection should be considered in patients with breast cancer who develop operable pulmonary metastases without evidence for concomitant extrapulmonary disease. In selected patients, such therapy may result in a survival benefit.

(Arch Surg. 1992;127:1282-1284)

Author Affiliations
From the Departments of General Surgery (Drs Staren, Salerno, Rongione, and Witt) and Cardiovascular-Thoracic Surgery (Dr Faber), Rush-Presbyterian—St Luke's Medical Center, Chicago, Ill.

Footnotes
Accepted for publication June 21, 1992.

Presented at the 45th Annual Cancer Symposium of the Society of Surgical Oncology, New York, NY, March 17, 1992.

Reprint requests to 1653 W Congress Pkwy, Chicago, IL 60612 (Dr Staren).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evaluation of Patients With Pulmonary Nodules: When Is It Lung Cancer?: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Gould et al.
Chest 2007;132:108S-130S.
ABSTRACT | FULL TEXT  

Accuracy of Helical CT in the Detection of Pulmonary Metastases: Is Intraoperative Palpation Still Necessary?
Parsons et al.
Ann. Thorac. Surg. 2004;78:1910-1918.
ABSTRACT | FULL TEXT  

A Role for Curative Surgery in the Treatment of Selected Patients with Metastatic Breast Cancer
Singletary et al.
The Oncologist 2003;8:241-251.
ABSTRACT | FULL TEXT  

Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the international registry of lung metastases
Friedel et al.
Eur. J. Cardiothorac. Surg. 2002;22:335-344.
ABSTRACT | FULL TEXT